Gilead has blamed the low rate of respiratory syncytial virus infections last season for ending two midstage trials of obeldesivir.

Gilead has been a leader in HIV innovation for decades. Now, we're proud to share that one of our researchers, Moupali Das, has been awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award for ...

In celebration of fathers, the Balm of Gilead Alternative Clinic, in collaboration with the New Tafo PIWC, held the second edition of the Legacy Fathers’ Awards to honour servicemen in Kumasi.

Gilead Sciences (GILD) shares fell Friday, a day after the biopharmaceutical firm reported weak sales of its COVID-19 and cancer treatments, and cut its full-year profit guidance.

Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma today announced a strategic partnership to accelerate the development and commercialization of LEO ...

The Balm of Gilead Grows Again, Maybe Daniel Silliman And other news from Christians around the world.

The usual sullen calm lay last week over the Biblical lands of Gilead, Moab and Ammon where King David once fought Absalom and where the British Crown now rules the mandated territory of ...

Just finished, with my breakfast, reading the latest essay in the New York Review of Books by Marilyn Robinson who, I fear, is writing less and less ...

From Mount Gilead each year, the Drs. Robinson ship thousands of gallons of medicine concocted from a secret formula which they purchased from respectable old Dr. Tucker before he died in 1920.

Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion, giving Gilead access to CymaBay's lead treatment for liver disease.